echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Nanjing jianyouda heparin sodium injection and low molecular weight heparin calcium injection were inspected on site this month

    Nanjing jianyouda heparin sodium injection and low molecular weight heparin calcium injection were inspected on site this month

    • Last Update: 2020-04-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to the website of the State Food and Drug Administration (CFDA) on June 17, the daparin sodium injection and low molecular weight heparin calcium injection declared by Nanjing Jianyou for production were inspected on site this month and are expected to obtain the product production approval document this year

    With the related products of many domestic enterprises approved in this year, the competition in the field of low molecular weight heparin preparation will be increasingly fierce

    Low molecular weight heparin is mainly used to prevent postoperative thromboembolism, pulmonary embolism, anticoagulation during cardiopulmonary bypass during hemodialysis, etc

    common low molecular weight heparin includes: heparin sodium, enoxaparin sodium, natroxobin calcium (low molecular weight heparin calcium), etc

    After sorting out, there will be a number of products in the field of low molecular weight heparin concentrated and approved for production this year

    At present, there are three domestic enterprises producing enoxaparin sodium preparations

    This year, enoxaparin sodium injection of Qianhong pharmaceutical, enoxaparin sodium injection of Chengdu Baiyu, enoxaparin sodium for injection and enoxaparin sodium for injection of Suzhou Erye are expected to join this camp

    Among them, Qianhong pharmaceutical and Chengdu Baiyu's related varieties have been notified to wait for on-site inspection at the end of March and last year respectively, and are now waiting for on-site inspection; Suzhou Erye's products have finished on-site inspection and entered the three in one review this month

    At present, there are five domestic enterprises producing low molecular weight heparin calcium preparations, and this year, Nanjing Jianyou and Dongcheng Pharmaceutical (002675

    SZ) are expected to be added

    Among them, Nanjing Jianyou's low molecular weight heparin calcium injection has been inspected on the production site this month; Dongcheng pharmaceutical's low molecular weight heparin calcium for injection has not made clear progress at present, but the company's management has repeatedly said that it is expected to obtain production approval in the second half of the year

    In contrast, there are few domestic enterprises producing heparin sodium preparation, only Changshan Pharmaceutical Co., Ltd

    obtained the first imitation production approval of heparin sodium injection in the middle of last month, and the product is expected to go on the market in the fourth quarter

    However, Changshan pharmaceutical's monopoly of the product market may be broken soon

    This month, Nanjing Jianyou's daparin sodium injection was inspected on the production site and is expected to be approved for production within this year

    As the price of heparin sodium API remains low and the gross profit of LMWH preparation is relatively high, Qianhong pharmaceutical, Nanjing Jianyou and other industry companies are extending to LMWH preparation with higher added value in succession, so as to reduce the impact of price fluctuation of API on the company's performance.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.